MakeMyTrip: Navigating Temporary Headwinds for Long-Term Growth
Finance

MakeMyTrip: Navigating Temporary Headwinds for Long-Term Growth

authorBy Suze Orman
DateJun 23, 2026
Read time3 min

MakeMyTrip (MMYT) presents a resilient investment opportunity, even as it navigates a period of moderated growth influenced by transient travel market disruptions. These recent slowdowns are not indicative of a structural decline in demand but rather a temporary market response. The company's diversified platform, encompassing hotels, travel packages, and bus services, has showcased considerable strength, effectively mitigating the impact of softer air travel demand. The current valuation, trading at 27 times next twelve months' price-to-earnings, appears particularly attractive. This lower valuation is primarily a consequence of market de-rating due to external conflicts, rather than any intrinsic deterioration in the company's fundamentals. With an anticipated easing of geopolitical pressures and sustained momentum in its non-air travel segments, MakeMyTrip is poised for a strong resurgence in both profitability and overall booking volumes.

MakeMyTrip's comprehensive ecosystem, designed to capture a broad spectrum of travel expenditures, has been a cornerstone of its strategy. My prior analysis highlighted MMYT's potential to expand its market share across various travel verticals, including accommodations, flights, ground transportation, and auxiliary services. This integrated platform is crucial for sustaining the company's long-term growth trajectory and maintaining its competitive edge in the evolving travel landscape.

The company's performance during these challenging times underscores the inherent stability of its business model. Despite external headwinds, the robust growth in hotel bookings, comprehensive travel packages, and bus services demonstrates the platform's ability to adapt and thrive. This diversified revenue stream reduces reliance on any single travel segment, providing a buffer against market fluctuations and ensuring consistent engagement with a broad customer base.

The current market valuation of MakeMyTrip offers a compelling entry point for investors. The price-to-earnings ratio, influenced by external events, does not fully reflect the company's underlying strengths or its future growth prospects. This disconnect presents a unique opportunity for those looking to invest in a market leader with a proven track record of resilience and innovation in the travel sector.

As the global travel industry gradually stabilizes and external disruptive factors diminish, MakeMyTrip is expected to capitalize on pent-up demand and its strengthened market position. The sustained growth in non-air segments will likely continue to drive earnings, while a recovery in air travel will provide an additional boost. This synergistic growth across its diverse offerings will be instrumental in accelerating its overall financial performance.

In essence, MakeMyTrip's current state, characterized by temporary growth deceleration and an attractive valuation, sets the stage for a significant rebound. The company's strategic focus on a broad travel portfolio, coupled with its operational resilience, positions it favorably for long-term value creation. Investors can anticipate a recovery in profitability and booking growth as market conditions improve and the company continues to execute on its expansive vision within the travel industry.

More Articles
Finance
Understanding SEC Section 16: Transparency in Stock Ownership
Section 16 of the Securities Exchange Act of 1934 plays a crucial role in maintaining transparency within public companies. This regulation mandates that key personnel and significant shareholders disclose their stock holdings and any changes to these holdings. The goal is to prevent insider trading and ensure fair dealings in the securities market by making such information publicly accessible through SEC filings.
By Fareed ZakariaJun 23, 2026
Finance
Atai Capital's Q1 2026 Performance and Portfolio Insights
Atai Capital recorded a 6.6% net gain in Q1 2026, outperforming major indices. The report details contributions from Haivision and the successful acquisition of AstroNova. It also provides an update on BK Technologies' ambitious Vision 2030 targets and prudent capital allocation strategy. Despite a growing cash reserve, the firm remains committed to selective, high-conviction investments, reflecting a disciplined approach to capital deployment.
By Michele FerreroJun 23, 2026
Finance
CTS Corporation: Refocusing Strategy and Valuation Outlook
CTS Corporation is transforming its business by shifting its focus from a legacy transportation segment to more diversified industrial, medical, aerospace, and defense markets. This strategic pivot has led to robust top-line growth and healthy EBITDA in recent quarters, demonstrating the potential of its new approach. Despite these positive developments and a solid balance sheet, the stock's current valuation suggests that these benefits are already priced in, leading to a neutral outlook.
By Lisa JingJun 23, 2026
Finance
Midstream MLPs Outperform Broader Market in Q1 2026
In the first quarter of 2026, the midstream master limited partnership (MLP) sector significantly outperformed the broader stock market, with the Alerian MLP Infrastructure Index rising by 17.16% while the S&P 500 Index declined by 4.33%. This strong performance highlights MLPs' potential as a valuable income-generating investment, particularly in a declining interest-rate environment. The sector's resilience and attractive income levels are proving beneficial for investors seeking steady returns.
By Morgan HouselJun 23, 2026
Finance
InfuSystem: A Promising Investment in Healthcare Services
InfuSystem, a micro-cap healthcare services company, presents a compelling investment opportunity. Despite a subdued market performance this year compared to other micro-caps, the company boasts a stable oncology-focused patient services segment, strong free cash flow yields, improving margins, and attractive valuations. Management's strategic initiatives, including reduced capital expenditures and ERP-driven efficiencies, are set to drive future growth, particularly in low-capital-intensive areas like wound care. While potential risks exist, InfuSystem's overall outlook remains positive.
By Mariana MazzucatoJun 23, 2026